Key result
Angiopoietin 2 reduces infarct volume and promotes angiogenesis in preclinical ischemic stroke.
Why the study?
The role of Angiopoietin 2-induced angiogenesis in neuroprotection and repair after ischemic stroke has not been fully elaborated.
Does Angiopoietin 2 administration reduce infarct volume and promote angiogenesis in a mouse model of ischemic stroke?
Does Angiopoietin 2 administration reduce infarct volume and promote angiogenesis in a mouse model of ischemic stroke?
Angiopoietin 2 demonstrates neuroprotective effects and promotes angiogenesis in a mouse model of ischemic stroke, suggesting a potential mechanism for post-stroke repair.
Hypothesis-generating for Angpt2 in post-stroke angiogenesis; leaves open translation to human ischemic stroke.
Angiogenic factors play an important role in protecting, repairing, and reconstructing vessels after ischemic stroke. In the brains of transient focal cerebral ischemic mice, we observed a reduction in infarct volume after the administration of Angiopoietin 2 (Angpt2), but whether this process is promoted by Angpt2-induced angiogenesis has not been fully elaborated. Therefore, this study explored the angiogenic activities, in reference to CD34 which is a marker of activated ECs and blood vessels, of cultured ECs in vitro and in ischemic damaged cerebral area in mice following Angpt2 administration. Our results demonstrate that Angpt2 administration (100 ng/mL) is neuroprotective by significantly increasing the CD34 expression in in vitro-cultured ECs, reducing the infarct volume and mitigating neuronal loss, as well as enhancing CD34+ vascular length and area. In conclusion, these results indicate that Angpt2 promotes repair and attenuates ischemic injury, and that the mechanism of this is closely associated with angiogenesis in the brain after stroke.
No takes yet. Share an insight, caveat, or question.
Lv et al. (2022) studied Ischemic stroke. Angiopoietin 2 (Angpt2) was evaluated on Infarct volume, neuronal loss, and CD34 expression/vascular length and area. Angiopoietin 2 administration (100 ng/mL) demonstrated neuroprotective effects by reducing infarct volume, mitigating neuronal loss, and enhancing angiogenesis in a mouse model of ischemic stroke.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: